HSP90AA1 and hepatocellular carcinoma: It mediates the ac4C modification of HSP90AA1 mRNA to upregulate HSP90AA1 expression levels, thus promoting HCC metastasis, antiapoptotic ability, and lenvatinib resistance [65].